SEARCH

SEARCH BY CITATION

References

  • 1
    Straus SE. History of chronic fatigue syndrome. Rev Infect Dis 1991; 13(Suppl.): 2 7.
  • 2
    Beard G. Neurasthenia, or nervous exhaustion. Boston Med Surg J 1869; 80: 217 20.
  • 3
    Johannisson K. Medicinens öga. Norstedts förlag. Stockholm: 1990.
  • 4
    Wessely S. Old wine in new bottles: neurasthenia and ‘ME’. Psychol Med 1990; 20: 35 53.
  • 5
    Freund JD. Psychoanalysis-uses and abuses. Psychosomatics 1972; 6: 377 9.
  • 6
    Ramsay AM & O’Sullivan E. Encephalomyelitis stimulating poliomyelitis. Lancet 1956; 1: 761 4.
  • 7
    Richardson AT. Some aspects of the Royal Free Hospital epidemic. Ann Phys Med 1956; 3: 81 9.
  • 8
    McEvedy CP & Beard AW. Royal Free epidemic of 1955: a reconsideration. Br Med J 1970; 1: 7 11.
  • 9
    Wessely S & Powell R. Fatigue syndromes: a comparison of chronic ‘postviral’ fatigue with neuromuscular and affective disorders. J Neurol Neurosurg Psychiatry 1989; 52: 940 48.
  • 10
    Fukuda K, Straus SE, Hickie I, et al. The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann Intern Med 1994; 121: 953 9.
  • 11
    Wessely S. The epidemiology of chronic fatigue syndrome. Epidemiol Rev 1995; 17: 139 51.
  • 12
    Hagnell O, Grasbeck A, Ojesjo L, Otterbeck L. Mental tiredness in the Lundby study. Incidence and course over 25 years. Acta Psychiatr Scand 1993; 88: 316 21.
  • 13
    Kroenke K, Arrington ME, Mangelsdorff AD. The prevalence of symptoms in medical outpatients and the adequacy of therapy. Arch Intern Med 1990; 150: 1685 9.
  • 14
    Bates DW, Schmitt W, Buchwald D, Ware N, Lee J, Thoyer E. Prevalence of fatigue and chronic fatigue syndrome in a primary care practice. Arch Intern Med 1993; 153: 2759 65.
  • 15
    Komaroff AL. ‘Minor’ illness symptoms: the magnitude of their burden and of our ignorance. Arch Intern Med 1990; 150: 1586 7.
  • 16
    Cox B, Blaxter M, Buckle J. The Health and Lifestyle Survey. London: Health Promotion Research Trust, 1987.
  • 17
    Buchwald D, Umali P, Umali J, Kith P, Pearlman T, Komaroff AL. Chronic fatigue and the chronic fatigue syndrome: prevalence in a Pacific Northwest heath care system. Ann Intern Med 1995; 123: 81 8.
  • 18
    Wessely S, Chalder T, Hirsch S, Wallace P, Wright D. The prevalence and morbidity of chronic fatigue and chronic fatigue syndrome: a prospective primary care study. Am J Publications Health 1997; 9: 1449 55.
  • 19
    Buchwald D & Garrity D. Comparisons of patients with chronic fatigue syndrome, fibromyalgia, and multiple chemical sensitivities. Arch Intern Med 1994; 154: 2049 53.
  • 20
    Nisenbaum R, Reyes M, Mawle AC, Reeves WC. Factor analysis of unexplained severe fatigtue and interrelated symptoms. Overlap with criteria for chronic fatigue syndrome. Am J Epidemiol 1998; 148: 72 7.
  • 21
    Komaroff AL, Fagioli LR, Doolittle TH, et al. Health status in patients with chronic fatigue syndrome and in general population and disease comparison groups. Am J Med 1996; 101: 281 90.
  • 22
    Buchwald D, Pearlman T, Kith P, Schmaling K. Gender differences in patients with chronic fatigue syndrome. J Gen Intern Med 1994; 9: 397 401.
  • 23
    Centers for Disease Control and Prevention. Chronic Fatigue Syndrome Research Program. Presented, U.S. Department of Health and Human Services, 1995.
  • 24
    Taerk GS, Toner BB, Salit IE, Garfinkel PE, Ozersky S. Depression in patients with neuromyasthenia [benign myalgic encephalomyelitis]. Int J Psychiatry Med 1987; 17: 49 56.
  • 25
    Hickie I, Lloyd A, Wakefield D, Parker G. The psychiatric status of patients with the chronic fatigue syndrome. Br J Psychiatry 1990; 156: 534 40.
  • 26
    Kruesi Mjp, Dale J, Straus SE. Psychiatric diagnoses in patients who have chronic fatigue syndrome. J Clin Psychiatry 1989; 50: 53 6.
  • 27
    Katon WJ, Buchwald DS, Simon GE, Russo JE, Mease PJ. Psychiatric illness in patients with chronic fatigue and those with rheumatoid arthritis. J Gen Intern Med 1991; 6: 277 85.
  • 28
    Pepper CM, Krupp LB, Friedberg F, Doscher C, Coyle PK. A comparison of neuropsychiatric characteristics in chronic fatigue syndrome, multiple sclerosis, and major depression. J Neuropsychiatry Clin Neurosci 1993; 5: 200 205.
  • 29
    Powell R, Dolan R, Wessely S. Attributions of self-esteem in depression and chronic fatigue syndromes. J Psychosom Res 1990; 34: 665 73.
  • 30
    Demitrack MA, Dale JK, Straus SE, et al. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. J Clin Endocrinol Metab 1991; 73: 1224 34.
  • 31
    Sharpe M, Clements A, Hawton K, Young AH, Sargent P, Cowen PJ. Increased prolactin response to buspirone in chronic fatigue syndrome. J Affect Disord 1996; 41: 71 6.
  • 32
    Bakheit Amo, Behan PO, Dinan TG, Gray CE, O’Keane V. Possible upregulation of hypothalamic 5-hydroxytryptamine receptors in patients with postviral fatigue syndrome. Br Med J 1992; 304: 1010 12.
  • 33
    Dinan TG. Neuroendocrinology of chronic fatigue syndrome. J Chronic Fatigue Syndrome 1996; 2: 69 70.
  • 34
    Schwartz RB, Komaroff AL, Garada BM, et al. SPECT imaging of the brain: comparison of findings in patients with chronic fatigue syndrome, AIDS dementia complex, and major unipolar depression. Am J Roentgenol 1994; 162: 943 51.
  • 35
    Kraepelin E. Clinical Psychiatry (transl. DefendorfR). London: Macmillan, 1902.
  • 36
    Dutil A. Neurasthénie in Traité de Pathologie Mentale (BalletG, ed.). Paris: Octave Doin, 1903;842 50.
  • 37
    Savill T. & Henry J, ed. Clinical Lectures on Neurasthenia. London: Glaisher, 1906.
  • 38
    Oppenheim H. Text-Book of Nervous Diseases for Physicians and Students, Vol II, 5th edn (transl BruceA). London: Fouli, 1911.
  • 39
    Sigal LH. Summary of the first 100 patients seen at a Lyme disease referral center. Am J Med 1990; 88: 577 81.
  • 40
    Steere AC, Taylor E, McHugh GL, Logigian EL. The overdiagnosis of Lyme disease. JAMA 1993; 269: 1812 16.
  • 41
    Coyle PK, Krupp LB, Doscher C, Amin K. Borrelia burgdorfen reactivity in patients with severe persistent fatigue who are from a region in which Lyme disease is endemic. Clin Infect Dis 1994; 18: S24 7.
  • 42
    Marmion BP, Shannon M, Maddocks I, Storm P, Penttila I. Protracted debility and fatigue after acute Q fever. Lancet 1996; 347: 977 8.
  • 43
    Lloyd AR, Wakefield D, Hickie I. Immunity and the pathophysiology of chronic fatigue syndrome. In: BockGR, WhelanJ, eds. Ciba Foundation Symposium 173, Chronic Fatigue Syndrome. New York: J. Wiley & Sons, 1993: 176 92.
  • 44
    Acheson ED. The clinical syndrome variously called benign myalgic encephalomyelitis, Iceland disease and epidemic neuromyasthenia. Am J Med 1959; 26: 569 95.
  • 45
    Henderson DA & Shelokov A. Epidemic neuromyasthenia –clinical syndrome? N Engl J Med 1959; 260: 757 64,814 18.
  • 46
    Gilliam AG. Epidemiologic study on an epidemic, diagnosed as poliomyelitis, occurring among the personnel of Los Angeles County General Hospital during the summer of 1934. Publications Health Bull 1938; 240: 1 90. Washington DC Public Health Service
  • 47
    Holmes GP, Kaplan JE, Stewart JA, Hunt B, Pinsky PF, Schonberger LB. A cluster of patients with a chronic mononucleosis–like syndrome. Is Epstein-Barr virus the cause? JAMA 1987; 257: 2297 302.
  • 48
    Daugherty SA, Henry BE, Peterson DL, Swarts RL, Bastien S, Thomas RS. Chronic fatigue syndrome in northern Nevada. Rev Infect Dis 1991; 13 Suppl.]: S39 S44.
  • 49
    Buchwald D, Cheney PR, Peterson DL, et al. A chronic illness characterized by fatigue, neurologic and immunologic disorders, and active human herpesvirus type 6 infection. Ann Intern Med 1992; 116: 103 13.
  • 50
    Straus SE, Tosato G, Armstrong G, et al. Persisting illness and fatigue in adults with evidence of Epstein–Barr virus infection. Ann Intern Med 1985; 102: 7 16.
  • 51
    Jones JF, Ray CG, Minnich LL, Hicks MJ, Kibler R, Lucas DO. Evidence for active Epstein-Barr virus infection in patients with persistent unexplained illnesses: elevated anti-early antigen antibodies. Ann Intern Med 1985; 102: 1 7.
  • 52
    Yalcin S, Kuratsune H, Yamaguchi K, Kitani T, Yamanishi K. Prevalence of human herpesvirus 6 variants A and B in patients with chronic fatigue syndrome. Microbiol Immunol 1994; 38: 587 90.
  • 53
    Patnaik M, Komaroff AL, Conley E, Ojo-Amaize EA, Peter JB. Prevalence of IgM antibodies to human herpesvirus 6 early antigen [p41/38] in patients with chronic fatigue syndrome. J Infect Dis 1995; 172: 1364 7.
  • 54
    Zorzenon M, Rukh G, Botta GA, Colle R, Barsanti LA, Ceccherini-Nelli L. Active HHV-6 infection in chronic fatigue syndrome patients from Italy: new data. J Chronic Fatigue Syndrome 1996; 2: 3 12.
  • 55
    Carrigan DR, Harrington DP, Knox KK. Subacute leukoencephalitis caused by CNS infection with human herpesvirus-6 manifesting as multiple sclerosis. Neurol 1996; 47: 145 8.
  • 56
    Caserta MT, Hall CB, Schnabel K, et al. Neuroinvasion and persistence of human herpesvirus-6 in children. J Infect Dis 1994; 170: 1586 9.
  • 57
    Challoner PB, Smith KT, Parker JD, et al. Plaque associated expression of human herpesvirus 6 in multiple sclerosis. Proc Natl Acad Sci USA 1995; 92: 7440 44.
  • 58
    DeFreitas E, Hilliard B, Cheney PR, Bell DS, Kiggundu E, Sankey D. Retroviral sequences related to human T-lymphotropic virus type II in patients with chronic fatigue immune dysfunction syndrome. Proc Natl Acad Sci USA 1991; 88: 2922 6.
  • 59
    Khan AS, Heneine WM, Chapman LE, et al. Assessment of a retrovirus sequence and other possible risk factors for the chronic fatigue syndrome. Ann Intern Med 1993; 118: 241 5.
  • 60
    Behan PO, Behan Wmh, Bell EJ. The postviral fatigue syndrome: an analysis of the findings in 50 cases. J Infect 1985; 10: 211 22.
  • 61
    Archard LC, Bowles NE, Behan PO, Bell EJ, Doyle D. Postviral fatigue syndrome: persistence of enteroviral RNA in muscle and elevated creatine kinase. J Soc Med 1988; 81: 326 9.
  • 62
    Yousef GE, Mann GF, Smith DG, Bell EJ, McCartney RA. Chronic enterovirus infection in patients with postviral fatigue syndrome. Lancet 1988; 1: 146 50.
  • 63
    Gow JW, Behan Wmh, Clements GB, Woodall C, Riding M, Behan PO. Enteroviral RNA sequences detected by polymerase chain reaction in muscle of patients with postviral fatigue syndrome. Br Med J 1991; 302: 692 6.
  • 64
    Lindh G, Samuelsson A, Hedlund KO, Evengard B, Lindquist L, Ehrnst A. No findings of enteroviruses in Swedish patients with chronic fatigue syndrome. Scand J Infect Dis 1996; 28: 305 7.
  • 65
    Swanink Cma, Melchers Wjg, Van deer Meer Jwm, Vercoulen JH, Bleijenberg G, Fennis JF, et al. Enteroviruses and the chronic fatigue syndrome. Clin Infect Dis 1994; 19: 860 64.
  • 66
    McArdle A, McArdle F, Jackson MJ, Page SF, Fahal I, Edwards RH. Investigation by polymerase chain reaction of enteroviral infection in patients with chronic fatigue syndrome. Clin Sci 1996; 90: 295 300.
  • 67
    Ludwig H, Bode L, Gosztonyi G. Borna disease: a persistent virus infection of the central nervous sytem. Prog Med Virol 1988; 35: 107 51.
  • 68
    Briese T, De La Torre JC, Lewis A, Ludwig H, Lipkin WI. Borna disease virus, a negative-strand RNA virus, transcribes in the nucleus of infected cells Proc Natl Acad Sci, USA 1992; 89: 11486 9.
  • 69
    Nakaya T, Takahashi H, Nakamura Y, et al. Demonstration of Borna disease virus RNA in peripheral blood mononuclear cells derived from Japanese patients with chronic fatigue syndrome. FEBS Lett 1996; 378: 145 9.
  • 70
    Kitani T, Kuratsune H, Fuke I, et al. Possible correlation between Borna disease virus infection and Japanese patients with chronic fatigue syndrome. Microbiol Immunol 1996; 40: 459 62.
  •  70a 
    Evergård B, Lindh G, Lipkin WI, Lee S. No evidence of Borna disease virus in patients with chronic fatigue syndrome. J Neurovirology : (in press).
  • 71
    Suhaldonik RJ, Reichenbach NL, Hitzges P, et al. Upregulation of the 2–5A synthetase/RNase L antiviral pathway associated with chronic fatigue syndrome. Clin Infect Dis 1994; 18(Suppl. 1): S96 104.
  • 72
    Suhaldonik RJ, Peterson DL, O’Brien K, et al. Biochemical evidence for a novel low molecular weight 2–5A-dependent RNase L in chronic fatigue syndrome. J Interferon Cytokine Res 1997; 17: 377 85.
  • 73
    Bates DW, Buchwald D, Lee J, et al. Clinical laboratory test findings in patients with chronic fatigue syndrome. Arch Intern Med 1995; 155: 97 103.
  • 74
    Landay AL, Jessop C, Lennette ET, Levy JA. Chronic fatigue syndrome: clinical condition associated with immune activation. Lancet 1991; 338: 707 12.
  • 75
    Straus SE, Fritz S, Dale JK, Gould B, Strober W. Lymphocyte phenotype and function in the chronic fatigue syndrome. J Clin Immunol 1993; 13: 30 40.
  • 76
    Klimas NG, Salvato FR, Morgan R, Fletcher MA. Immunologic abnormalities in chronic fatigue syndrome. J Clin Microbiol 1990; 28: 1403 10.
  • 77
    Tirelli U, Pinto A, Marotta G, et al. Clinical and immunologic study of 205 patients with chronic fatigue syndrome: a case series from Italy. Arch Intern Med 1993; 153: 116 17.
  • 78
    Aoki T, Usuda Y, Miyakoshi H, Tamura K, Herberman RB. Low natural killer syndrome: clinical and immunologic features. Nat Immun Cell Growth Regul 1987; 6: 116 28.
  • 79
    Caligiuri M, Murray C, Buchwald D, et al. Phenotypic and functional deficiency of natural killer cells in patients with chronic fatigue syndrome. J Immunol 1987; 139: 3306 13.
  • 80
    Eby NL, Grufferman S, Huang M, et al. Natural killer cell activity in the chronic fatigue–immune dysfunction syndrome. In: AdesEW, LopezC, eds. Natural Killer Cells and Host Defense. Basel : Karger, 1989; 141 5.
  • 81
    Morrison Lja, Behan Wmh, Behan PO. Changes in natural killer cell phenotype in patients with post–viral fatigue syndrome. Clin Exp Immunol 1991; 83: 441 6.
  • 82
    Grufferman S, Levine PH, Eby NL, et al. Results of an investigation of three clusters of chronic fatigue syndrome. Clin Infect Dis 1994; 18(Suppl.1): S55 6.
  • 83
    Ojo-Amaize EA, Conley EJ, Peter JB. Decreased natural killer cell activity is associated with severity of chronic fatigue immune dysfunction syndrome. Clin Infect Dis 1994; 18(Suppl. 1): S157 9.
  • 84
    Gupta S & Vayuvegula B. A comprehensive immunological analysis in chronic fatigue syndrome. Scand J Immunol 1991; 3: 319 27.
  • 85
    Lloyd A, Hickie I, Hickie C, Dwyer J, Wakefield D. Cell-mediated immunity in patients with chronic fatigue syndrome, healthy control subjects and patients with major depression. Clin Exp Immunol 1992; 87: 76 9.
  • 86
    Konstantinov K, Von Mikecz A, Buchwald D, Jones J, Gerace L, Tan EM. Autoantibodies to nuclear envelope antigens in chronic fatigue syndrome. J Clin Invest 1996; 98: 1888 96.
  • 87
    Peakman M, Deale A, Field R, Mahalingam M, Wessely S. Clinical improvement in chronic fatigue syndrome is not associated with lymphocyte subsets of function or activation. Clin Immunol Immunopathol 1997; 82: 83 91.
  • 88
    Bennett AL, Chao CC, Hu S, et al. Elevation of bioactive transforming growth factor-beta in serum from patients with chronic fatigue syndrome. J Clin Immunol 1997; 17: 160 66.
  • 89
    Chao CC, Gallagher M, Phair J, Peterson PK. Serum neopterin and interleukin-6 levels in chronic fatigue syndrome. J Infect Dis 1990; 162: 1412 13.
  • 90
    Linde A, Andersson B, Svenson SB, et al. Serum levels of lymphokines and soluble cellular receptors in primary Epstein-Barr virus infection and in patients with chronic fatigue syndrome. J Infect Dis 1992; 165: 994 1000.
  • 91
    Chao CC, Janoff EN, Hu SX, et al. Altered cytokine release in peripheral blood mononuclear cell cultures from patients with the chronic fatigue syndrome. Cytokine 1991; 3: 292 8.
  • 92
    Gupta S, Aggarwal S, See D, Starr A. Cytokine production by adherent and non-adherent mononuclear cells in chronic fatigue syndrome. J Psychiatr Res 1997; 31: 149 56.
  • 93
    Cannon JG, Angel JB, Abad LW, et al. Interleukin-1 beta, interleukin-1 receptor antagonist, and soluble interleukin-1 receptor type II secretion in chronic fatigue syndrome. J Clin Immunol 1997; 17: 253 61.
  • 94
    Edwards RH, Gibson H, Clague JE, Helliwell T. Muscle histopathology and physiology in chronic fatigue syndrome. In: BockGR, WhelanJ, eds. Chronic Fatigue Syndrome Chichester : John Wiley & Sons, 1993; 102 31.
  • 95
    Gibson H, Carroll N, Clague JE, Edwards RH. Exercise performance and fatiguability in patients with chronic fatigue syndrome. J Neurol Neurosurg Psychiatry 1993; 56: 993 8.
  • 96
    Lloyd AR, Hales JR, Gandevia SC. Muscle strength, endurance and recovery in the post–infection fatigue syndrome. J Neurol Neurosurg Psychiatry 1988; 51: 1316 22.
  • 97
    Natelson BH, Cohen JM, Brassloff I, Lee H-J. A controlled study of brain magnetic resonance imaging in patients with the chronic fatigue syndrome. J Neurol Sci 1993; 120: 213 17.
  • 98
    Ichise M, Salit IE, Abbey SE, et al. Assessment of regional cerebral perfusion by 99Tcm-HMPAO SPECT in chronic fatigue syndrome. Nucl Med Commun 1992; 13: 767 72.
  • 99
    Costa DC, Tannock C, Brostoff J. Brainstem perfusion is impaired in chronic fatigue syndrome. Q J Med 1995; 88: 767 73.
  • 100
    Cope H & David AS. Neuroimaging in chronic fatigue syndrome. J Neurol Neurosurg Psychiatry 1996; 60: 471 3.
  • 101
    Bou-Holaigah I, Rowe PC, Kan J, Calkins H. The relationship between neurally mediated hypotension and the chronic fatigue syndrome. JAMA 1995; 274: 961 7.
  • 102
    Freeman R & Komaroff AL. Does the chronic fatigue syndrome involve the autonomic nervous system? Am J Med 1997; 102: 357 64.
  • 103
    Demitrack MA, Gold PW, Dale JK, Krahn DD, Kling MA, Straus SE. Plasma and cerebrospinal fluid monamine metabolism in patients with chronic fatigue syndrome: preliminary findings. Biol Psychiatry 1992; 32: 1065 77.
  • 104
    Cleare AJ, Bearn J, Allain T, et al. Contrasting neuroendocrine responses in depression and chronic fatigue syndrome. J Affect Disord 1995; 35: 283 9.
  • 105
    Furman JmR. Testing of vestibular function: an adjunct in the assessment of chronic fatigue syndrome. Rev Infect Dis 1991; 13(Suppl. 1): S109 11.
  • 106
    Ash-Bernal R, Wall C III, Komaroff AL, et al. Vestibular function test anomalies in patients with chronic fatigue syndrome. Acta Otolaryngol 1995; 115: 9 17.
  • 107
    Abbey SE & Garfinkel PE. Chronic fatigue syndrome and depression: cause, effect, or covariate. Rev Infect Dis 1991; 13(Suppl.): 73 83.
  • 108
    Komaroff AL. Post–viral fatigue syndrome: a review of American research and practice. In: JenkinsR, MowbrayJ, eds. Post–Viral Fatigue Syndrome. West Sussex, UK: John Wiley & Sons, 1991;41 59.
  • 109
    Grafman J, Johnson R Jr, Scheffers M. Cognitive and mood-state changes in patients with chronic fatigue syndrome. Rev Infect Dis 1991 ; ( Suppl. 1): 45 52.
  • 110
    Johnson SK, DeLuca J, Fiedler N, Natelson BH. Cognitive functioning of patients with chronic fatigue syndrome. Clin Infect Dis 1994; 18(Suppl. 1): S84 5.
  • 111
    Marcel B, Komaroff AL, Fagioli LR, Kornish RJ, Albert MS. Cognitive deficits in patients with chronic fatigue syndrome. Biol Psychiatry 1996; 40: 535 41.
  • 112
    Michiels V, Cluydts R, Fischler B, Hoffmann G, Le Bon O, De Meirleir K. Cognitive functioning in patients with chronic fatigue syndrome. J Clin Exp Neuropsychol 1996; 18: 666 77.
  • 113
    DeLuca J, Johnson SK, Beldowicz D, Natelson BH. Neuropsychological impairments in chronic fatigue syndrome, multiple sclerosis, and depression. J Neurol Neurosurg Psychiatry 1995; 58: 38 43.
  • 114
    DeLuca J, Johnson SK, Ellis SP, Natelson BH. Cognitive functioning is impaired in patients with chronic fatigue syndrome devoid of psychiatric disease. J Neurol Neurosurg Psychiatry 1997; 62: 151 5.
  • 115
    DeLuca J, Johnson SK, Ellis SP, Natelson BH. Sudden vs gradual onset of chronic fatigue syndrome differentiates individuals on cognitive and psychiatric measures. J Psychiatr Res 1997; 31: 83 90.
  • 116
    Tiersky LA, Johnson SK, Lange G, Natelson BH, DeLuca J. Neuropsychology of chronic fatigue syndrome: a critical review. J Clin Exp Neuropsychol 1997; 19: 560 86.
  • 117
    Moldofsky H. Fibromyalgia, sleep disorder, and chronic fatigue syndrome. In: BockGR, WhelanJ, eds. Chronic Fatigue Syndrome, Ciba Found Symp, New York: John Wiley & Sons, 1993 : 262 71.
  • 118
    Krupp LB, Jandorf L, Coyle PK, Mendelson WB. Sleep disturbance in chronic fatigue syndrome. J Psychosom Res 1993; 37: 325 31.
  • 119
    Buchwald D, Pascualy R, Bombardier C, Kith P. Sleep disorders in patients with chronic fatigue. Clin Infect Dis 1994; 18(Suppl. 1): S68 72.
  • 120
    Oldstone MB, Holmstoen J, Welsh Rm Jr. Alterations of acetylcholine enzymes in neuroblastoma cells persistently infected with lymphocytic choriomeningitis virus. J Cell Physiol 1977; 91: 459 72.
  • 121
    Oldstone MB, Sinha YN, Blount P, et al. Virus-induced alterations in homeostasis: alterations in differentiated functions of infected cells in vivo. Science 1982; 218: 1125 7.
  • 122
    Preeyasombat C, Richards C, Silverman M, Kenny FM. Cortisol production. III. Rubella and varicella encephalopathy, with a note on their treatment with steroids. Am J Dis Child 1965; 110: 370 73.
  • 123
    White MG, Carter NW, Rector FC, et al. Pathophysiology of epidemic St. Louis encephalitis. I. Inappropriate secretion of antidiuretic hormone. II. Pituitary-adrenal function. III. Cerebral blood flow and metabolism. Ann Intern Med 1969; 71: 691 702.
  • 124
    Zeitoun MM, Hassan AI, Hussein ZM, Fahmy MS, Ragab M, Hussein M. Adrenal glucocorticoid function in acute viral infections in children. Acta Paediatr Scand 1973; 62: 608 14.
  • 125
    Merenich JA, McDermott MT, Asp AA, Harrison SM, Kidd GS. Evidence of endocrine involvement early in the course of human immunodeficiency virus infection. J Clin Endocrinol Metab 1990; 3: 566 71.
  • 126
    Lane C. The mental element in the etiology of neurasthenia. J Nervous Mental Dis 1906; 33: 463 6.
  • 127
    Beard G. American Nervousness. New York: GP Putnam, 1881.
  • 128
    Chalder T, Power MJ, Wessely S. Chronic fatigue in the community: ‘a question of attribution. Psychol Med 1996; 26: 791 800.
  • 129
    Esterling BA, Antoni MH, Schneiderman N, et al. Psychosocial modulation of antibody to Epstein–Barr viral capsid antigen and human herpesvirus type-6 in HIV-1 infected and at-risk gay men. Psychosom Med 1992; 54: 354 71.
  • 130
    Cohen S, Tyrrell DA, Smith AP. Psychological stress and susceptibility to the common cold. N Engl J Med 1991; 325(9): 606 12.
  • 131
    Gold PW, Chrousos GP, Kellner C, Post R, Augerinos P, Schulte H. Psychiatric implications of basic and clinical studies with corticotropin releasing hormone. Am J Psychiatry 1984; 141: 619 27.
  • 132
    Roy A, Pickar D, Paul SM, Doran A, Chrousos GP, Gold PW. CSF corticotropin releasing hormone in depressed patients and normal control subjects. Am J Psychiatry 1987; 144: 641 5.
  • 133
    Yehuda R, Giller EL, Southwick SM, Lowy MT, Mason JW. Hypothalamic-pituitary-adrenal dysfunction in post-traumatic stress disorder. Biol Psychiatry 1991; 30: 1031 48.
  • 134
    Michelson d Gold PW & Sternberg EM. The stress response in critical illness. New Horiz 1994; 2: 426 31.
  • 135
    Michelson D & Gold PW. Pathophysiologic and somatic investigations of hypothalamic-pituitary-adrenal axis activation in patients with depression. Ann N Y Acad Sci 1998; 840: 717 22.
  • 136
    Licinio J, Gold PW, Wong ML. A molecular mechanism for stress-induced alterations in susceptibility to disease. Lancet 1995; 346: 104 6.
  • 137
    Gold PW, Licinio J, Wong ML, Chrousos GP. Corticotropin releasing hormone in the pathophysiology of melancholic and atypical depression and in the mechanism of action of antidepressant drugs. Ann N Y Acad Sci 1995; 771: 716 29.
  • 138
    Demitrack M. Chronic fatigue syndrome: a disease of the hypothalamic-pituitary-adrenal axis? Ann Med 1994; 26: 1 5.
  • 139
    Demitrack MA & Crofford LJ. Evidence for and pathophysiologic implications of hypothalamic-pituitary-adrenal axis dysregulation in fibromyalgia and chronic fatigue syndrome. Ann N Y Acad Sci 1998; 840: 684 97.
  • 140
    Scott LV & Dinan TG. Urinary free cortisol excretion in chronic fatigue syndrome, major depression and in healthy volunteers. J Affect Disord 1998; 47: 49 54.
  • 141
    Scott LV, Medbak S, Dinan TG. Blunted adrenocorticotropin and cortisol responses to corticotropin-releasing hormone stimulation in chronic fatigue syndrome. Acta Psychiatr Scand 1998; 97: 450 57.
  • 142
    Young AH, Sharpe M, Clements A, Dowling B, Hawton KE, Cowen PJ. Basal activity of the hypothalamic-pituitary-adrenal axis in patients with the chronic fatigue syndrome [neurasthenia]. Biol Psychiatry 1998; 43: 236 7.
  • 143
    Evengård B, Nilsson CG, Lindh G et al. No evidence for elevated substance P levels in cerebrospinal fluid of patients with CFS. Pain 1998; 78: 153 155.
  • 144
    Allain TJ, Bearn JA, Coskeran P, et al. Changes in growth hormone, insulin, insulin-like growth factors [IGFs], and IGF-binding protein-1 in chronic fatigue syndrome. Biol Psychiatry 1997; 41: 567 73.
  • 145
    Lutgendorf SK, Antoni MH, Ironson G, et al. Physical symptoms of chronic fatigue syndrome are exacerbated by the stress of hurricane Andrew. Psychosom Med 1995; 57: 310 23.
  • 146
    Blalock JE. The syntax of immune-neuroendocrine communication. Immunol Today 1994; 15: 504 11.
  • 147
    Grossman A & Costa A. The regulation of hypothalamic CRH: impact of in vitro studies on the central control of the stress response. Funct Neurol 1993; 8: 325 34.
  • 148
    Goldenberg DL, Felson DT, Dinerman H. A randomized, controlled trial of amitriptyline and naproxen in the treatment of patients with fibromyalgia. Arthritis Rheum 1986; 29: 1371 7.
  • 149
    Carette S, Bell MJ, Reynolds WJ. Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia. Arthritis Rheum 1994; 1: 32.
  • 150
    Vercoulen Jhmm, Swanink Cma, Zitman FG, et al. Randomised, double-blind, placebo-controlled study of fluoxetine in chronic fatigue syndrome. Lancet 1996; 347: 858 61.
  • 151
    Natelson BH, Cheu J, Pareja J, Ellis SP, Policastro T, Findley TW. Randomized, double blind, controlled placebo-phase in trial of low dose phenelzine in chronic fatigue syndrome. Psychopharmacology (Berl ) 1996; 124: 226 30.
  • 152
    Straus SE, Dale JK, Tobi M, et al. Acyclovir treatment of the chronic fatigue syndrome. Lack of efficacy in a placebo-controlled trial. N Engl J Med 1988; 319(26): 1692 8.
  • 153
    Strayer DR, Carter WA, Brodsky I, et al. A controlled clinical trial with a specifically configured RNA drug, poly[I]·poly[C12U], in chronic fatigue syndrome. Clin Infect Dis 1994; 18(Suppl. 1): S88 95.
  • 154
    Plioplys AV & Plioplys S. Amantadine and l-carnitine treatment of chronic fatigue syndrome. Neuropsychobiology 1997; 35: 16 23.
  • 155
    Steinberg P, McNutt BE, Marshall P, et al. Double-blind placebo-controlled study of the efficacy of oral terfenadine in the treatment of chronic fatigue syndrome. J Allergy Clin Immunol 1996; 97: 119 26.
  • 156
    See DM & Tilles JG. Alpha-interferon treatment of patients with chronic fatigue syndrome. Immunol Invest 1996; 25: 153 64.
  • 157
    Peterson PK, Shepard J, Macres M, et al. A controlled trial of intravenous immunoglobulin G in chronic fatigue syndrome. Am J Med 1990; 89: 554 60.
  • 158
    Vollmer-Conna U, Hickie I, Hadzi-Pavlovic D, et al. Intravenous immunoglobulin is ineffective in the treatment of patients with chronic fatigue syndrome. Am J Med 1997; 103: 38 43.
  • 159
    McKenzie R, O’Fallon A, Dale J, et al. Low-dose hydrocortisone for treatment of chronic fatigue syndrome. JAMA 1998; 280: 1061 6.
  • 160
    Sharpe M. Non-pharmacological approaches to treatment. In: BockGR, WhelanJ, eds. Chronic Fatigue Syndrome, Ciba Found Symp 173. New York: John Wiley & Sons, 1993; 298 317.
  • 161
    Lloyd AR, Hickie I, Brockman A, et al. Immunologic and psychologic therapy for patients with chronic fatigue syndrome: a double-blind, placebo-controlled trial. Am J Med 1993; 94: 197 203.
  • 162
    Sharpe M, Hawton K, Simkin S, et al. Cognitive behaviour therapy for the chronic fatigue syndrome: a randomized controlled trial. Br Med J 1996; 312: 22 6.
  • 163
    Sharpe M. Cognitive behaviour therapy for chronic fatigue syndrome: efficacy and implications. Am J Med 1998; 105: 104 9.
  • 164
    Sharpe M, Chalder T, Palmer I, Wessely S. Chronic fatigue syndrome. A practical guide to assessment and management. Gen Hosp Psychiatry 1997; 19: 185 99.
  • 165
    Joyce J, Hotopf M, Wessely S. The prognosis of chronic fatigue and chronic fatigue syndrome: a systematic review. Q J Med 1997; 90: 223 33.